Metalloprotease ADAM10 inhibition mitigates acute liver injury via repression of intrahepatic inflammation

A Functional Polymorphism-Mediated Disruption of EGR1/ADAM10 Pathway Confers the Risk of Sepsis Progression

(2019) Feng Chen et al.   mBio

miR-23b Negatively Regulates Sepsis-Induced Inflammatory Responses by Targeting ADAM10 in Human THP-1 Monocytes

(2019) Wenying Zhang et al.   MEDIATORS OF INFLAMMATION

Platelet-Derived Exosomal MicroRNA-25-3p Inhibits Coronary Vascular Endothelial Cell Inflammation Through Adam10 via the NF-κB Signaling Pathway in ApoE−/− Mice

(2019) Ye Yao et al.   Frontiers in Immunology

Autophagy and apoptosis in liver injury

(2015) Kewei Wang   CELL CYCLE

The Antiatherogenic Effect of Fish Oil in Male Mice Is Associated with a Diminished Release of Endothelial ADAM17 and ADAM10 Substrates

(2015) Nancy Speck et al.   JOURNAL OF NUTRITION

Kupffer cells-dependent inflammation in the injured liver increases recruitment of mesenchymal stem cells in aging mice

(2015) Xue Yang et al.   Oncotarget

Expression profile of ADAM10 and ADAM17 in allergic rhinitis

(2015) Hee Won Chueh et al.   International Forum of Allergy & Rhinology

The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease

(2015) Gurkan Celebi et al.   Saudi Journal of Gastroenterology

Inhibition of hepatocyte autophagy increases tumor necrosis factor-dependent liver injury by promoting caspase-8 activation

(2013) M Amir et al.   CELL DEATH AND DIFFERENTIATION

Disturbed Follicular Architecture in B Cell A Disintegrin and Metalloproteinase (ADAM)10 Knockouts Is Mediated by Compensatory Increases in ADAM17 and TNF-  Shedding

(2013) L. Folgosa et al.   JOURNAL OF IMMUNOLOGY

siRNA knockdown of ADAM-10, but not ADAM-17, significantly reduces fractalkine shedding following pro-inflammatory cytokine treatment in a human adult brain endothelial cell line

(2012) Louise A. Hurst et al.   NEUROSCIENCE LETTERS

Unknown

(2011) Christoph Menzel et al.   MOLECULAR MEDICINE

Triptolide: An inhibitor of a disintegrin and metalloproteinase 10 (ADAM10) in cancer cells

(2010) Ramani Soundararajan et al.   CANCER BIOLOGY & THERAPY

ADAM10 as a Therapeutic Target for Cancer and Inflammation

(2009) Howard Crawford et al.   CURRENT PHARMACEUTICAL DESIGN